These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4613772)

  • 21. [Urinary 17-ketosteroid excretion and serum 17-hydroxycorticosteroid levels during treatment of prostate cancer patients].
    Portnoĭ AS; Parfent'eva LN
    Vopr Onkol; 1969; 15(12):30-4. PubMed ID: 5372969
    [No Abstract]   [Full Text] [Related]  

  • 22. Endocrine therapy and serum and urinary testosterone levels, as a monitoring, in patients with carcinoma of the prostate.
    Oka M; Nakashima K
    Nihon Gan Chiryo Gakkai Shi; 1977 Sep; 12(3):336-42. PubMed ID: 915355
    [No Abstract]   [Full Text] [Related]  

  • 23. Hormonal therapy of prostatic cancer.
    Scott WW; Menon M; Walsh PC
    Cancer; 1980 Apr; 45(7 Suppl):1929-36. PubMed ID: 7370944
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of prostatic carcinoma from the endocrinologic viewpoint].
    Rothauge CF; Wildberger JE; Szasz G; Graef V
    Urologe; 1969; 8(5):237-9. PubMed ID: 5359388
    [No Abstract]   [Full Text] [Related]  

  • 25. Intraductal carcinoma of the prostate gland.
    Rhamy RK; Buchanan RD; Spalding MJ
    Trans Am Assoc Genitourin Surg; 1972; 64():61-8. PubMed ID: 4654524
    [No Abstract]   [Full Text] [Related]  

  • 26. Management of prostate carcinoma.
    Whitehead ED
    N Y State J Med; 1981 Sep; 81(10):1481-5. PubMed ID: 7024862
    [No Abstract]   [Full Text] [Related]  

  • 27. [Complete hormonal block vs. simple hormonal block in the treatment of carcinoma of the prostate].
    Berenguer Sánchez A
    Arch Esp Urol; 2002 Sep; 55(7):771-5. PubMed ID: 12380304
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of prostatic carcinoma from the urological viewpoint].
    Burchardt P
    Rontgenblatter; 1973 Oct; 26(10):432-4. PubMed ID: 4752187
    [No Abstract]   [Full Text] [Related]  

  • 29. [Aspects of prostatic carcinoma for the general practice].
    Frick J
    Z Allgemeinmed; 1971 Mar; 47(7):334-6. PubMed ID: 5558580
    [No Abstract]   [Full Text] [Related]  

  • 30. [Regression and disappearance of bone metastasis in a case of prostatic carcinoma after bilateral orchidectomy and oestrogen therapy (author's transl)].
    Suhler A
    J Urol (Paris); 1981; 87(4):227-9. PubMed ID: 7264352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hormone therapy in carcinoma of the prostate].
    Marberger H
    Wien Klin Wochenschr; 1966 Jul; 78(29):512-4 passim. PubMed ID: 5992834
    [No Abstract]   [Full Text] [Related]  

  • 32. Editorial: The choice of therapy for prostatic carcinoma.
    Marshall VF
    J Urol; 1975 Mar; 113(3):285. PubMed ID: 46926
    [No Abstract]   [Full Text] [Related]  

  • 33. Endocrine treatment: expected duration stage by stage.
    Schröder FH
    Prostate Suppl; 2000; 10():26-31. PubMed ID: 11056490
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of carcinoma. Hormonal treatment and orchiectomy.
    Barnes RW
    Postgrad Med; 1969 Jun; 45(6):171 passim. PubMed ID: 5789387
    [No Abstract]   [Full Text] [Related]  

  • 35. [Present situation of treatment of cancer of the prostate].
    Röhl L; Hallwachs O
    Langenbecks Arch Chir; 1965 Aug; 311(3):263-71. PubMed ID: 5853898
    [No Abstract]   [Full Text] [Related]  

  • 36. Some aspects of carcinoma of the prostate.
    Cook EN
    Br J Urol; 1970 Dec; 42(6):742-3. PubMed ID: 5491935
    [No Abstract]   [Full Text] [Related]  

  • 37. [Fibrinolysis in prostate carcinomas of varying grades of differentiation with respect to estrogen therapy and castration].
    Oehler D; Feustel A
    Z Urol Nephrol; 1980 Mar; 73(3):201-10. PubMed ID: 7434984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostatic cancer: endocrine treatment.
    Chisholm GD
    Turk J Pediatr; 1984; 26(1-4):273-6. PubMed ID: 6537080
    [No Abstract]   [Full Text] [Related]  

  • 39. Patterns of care for carcinoma of the prostate gland: results of a national survey of 1984 and 1990.
    Jones GW; Mettlin C; Murphy GP; Guinan P; Herr HW; Hussey DH; Chmiel JS; Fremgen AM; Clive RE; Zuber-Ocwieja KE
    J Am Coll Surg; 1995 May; 180(5):545-54. PubMed ID: 7538405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant immunotherapy (BCG) in stage D prostate cancer.
    Guinan PD; John T; Baumgartner G; Sundar B; Ablin RJ
    Am J Clin Oncol; 1982 Feb; 5(1):65-8. PubMed ID: 7081139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.